Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Prospective, Non-interventional Study, to Assess Real World Use of a Tocilizumab Biosimilar in Rheumatoid Arthritis Patients

NCT06247722 is registered in ClinicalTrials.gov with Fresenius Kabi SwissBioSim GmbH as lead sponsor.

NCT NCT06247722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06247722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Prospective, Non-interventional Study, to Assess Real World Use of a Tocilizumab Biosimilar in Rheumatoid Arthritis Patients
Lead sponsor
Fresenius Kabi SwissBioSim GmbH
Phase
Observational
Overall status
Active, not recruiting
Start date
March 5, 2024
Completion date
March 31, 2026
Enrollment
600 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis